PubRank

M T Pato

Author PubWeight™ 33.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. Am J Med Genet 2001 2.48
2 Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet 2004 2.41
3 Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 2008 2.07
4 Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. Am J Psychiatry 1997 1.67
5 Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry 2012 1.57
6 Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry 1990 1.46
7 Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 2005 1.44
8 Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry 2005 1.34
9 Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 2004 1.24
10 Genome-wide scan in Portuguese Island families implicates multiple loci in bipolar disorder: fine mapping adds support on chromosomes 6 and 11. Am J Med Genet B Neuropsychiatr Genet 2004 1.10
11 GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry 2010 1.00
12 Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene. Mol Psychiatry 2003 0.94
13 Comorbidity of obsessive-compulsive and psychotic symptoms: a review. Harv Rev Psychiatry 1997 0.93
14 Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol 1991 0.89
15 Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. Am J Med Genet 1993 0.89
16 Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. Br J Psychiatry Suppl 1989 0.87
17 Selection of homogeneous populations for genetic study: the Portugal genetics of psychosis project. Am J Med Genet 1997 0.86
18 Detection of expansion regions in Portuguese bipolar families. Am J Med Genet 2000 0.85
19 Long repeat tracts at SCA8 in major psychosis. Am J Med Genet 2000 0.84
20 Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet 2000 0.82
21 Current issues in the pharmacologic management of obsessive compulsive disorder. J Clin Psychiatry 1993 0.80
22 Neurologic soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry 1991 0.79
23 Association and linkage disequilibrium between a functional polymorphism of the dopamine-2 receptor gene and schizophrenia in a genetically homogeneous Portuguese population. Mol Psychiatry 2002 0.79
24 Olanzapine prolongation of granulocytopenia after clozapine discontinuation. J Clin Psychopharmacol 2000 0.79
25 A curriculum for producing resident researchers. Acad Med 1999 0.78
26 Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior. Am J Psychiatry 1998 0.78
27 A time-limited behavioral group for treatment of obsessive-compulsive disorder. J Psychother Pract Res 1998 0.76
28 Integrating genetic, functional genomic, and bioinformatics data in a systems biology approach to complex diseases: application to schizophrenia. Methods Mol Biol 2007 0.76
29 Possible risperidone-induced tardive dystonia. Ann Pharmacother 2000 0.76
30 A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder. J Clin Psychopharmacol 1991 0.76
31 Serotonin and effect sizes of antiobsessive agents. Am J Psychiatry 1992 0.75
32 Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. J Clin Psychiatry 2001 0.75
33 Summary of the Third World Congress on Psychiatric Genetics. Am J Med Genet 1993 0.75
34 Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents. J Clin Psychopharmacol 1990 0.75
35 Genetic analyses of schizophrenia. Curr Psychiatry Rep 2000 0.75
36 Social phobia and stuttering. Am J Psychiatry 1996 0.75